This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25
25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25
FDA Warning In 2012, the FDA issued a warning about potentially adverse neurocognitive effects of statin therapy based mostly on observational data and rare case reports 2. The FDA warning was issued in 2012. 2012 Aug 11;380(9841):581-90. 2012 Mar;53(3):567-576. Share So What Does The Data Say? J Lipid Res.
Background:The association between left ventricular injury (LVI) detected by cardiac magnetic resonance imaging (CMR) and the risk of a subsequent ischemic stroke is unknown.Methods:We studied stroke-free participants in the Multi-Ethnic Study of Atherosclerosis study who underwent a steady-state free precession CMR at Exam 5 (2010-2012).
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. 2012 Mar;53(3):567-576. Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):431-8. doi: 10.1161/ATVBAHA.108.179564. 108.179564. PMID: 19299327; PMCID: PMC2740366. 9 Sato Y, Suzuki I, Nakamura T, Bernier F, Aoshima K, Oda Y. J Lipid Res.
Annals of Emergency Medicine 2012; 60(12):766-776. 18 , 19 First, the derivation of the original Sgarbossa criteria utilized a biomarker (creatinine kinase-MB) definition of AMI, resulting in a case group of patients with both occlusion myocardial infarction and nonocclusion myocardial infarction.
Hunter Mehaffey Distressed communities are associated with worse outcomes after coronary artery bypass surgery The Journal of Thoracic and Cardiovascular Surgery August 2019 Meghana Helder Regional and Temporal Trends in the Outcomes of Repairs for Acute Type A Aortic Dissections The Annals of Thoracic Surgery August 2019 Derrick Tam Surgical valve (..)
Hunter Mehaffey 1 Distressed communities are associated with worse outcomes after coronary artery bypass surgery The Journal of Thoracic and Cardiovascular Surgery August 2019 Meghana Helder 2 Regional and Temporal Trends in the Outcomes of Repairs for Acute Type A Aortic Dissections The Annals of Thoracic Surgery August 2019 Derrick Tam 2 Surgical (..)
plus drug supply BEST-D pilot trial of vitamin D (2012-2014) Tishcon: free drug supply only Big Data Institute (2018-2021) Novartis Pharma AG Switzerland: £272K Can wearables improve the prediction of all-cause mortality, cardiovascular disease, and cancer in UK Biobank? plus drug supply Bayer: £1.8M
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content